Xanthine oxidase inhibition and white matter hyperintensity progression following ischaemic stroke and transient ischaemic attack (XILO-FIST): a multicentre, double-blinded, randomised, placebo-controlled trial

Dawson, Jesse; Robertson, Michele; Dickie, David Alexander; Bath, Phillip; Forbes, Kirsten; Quinn, Terence; Broomfield, Niall M.; Dani, Krishna; Doney, Alex; Houston, Graeme; Lees, Kennedy R.; Muir, Keith W.; Struthers, Allan; Walters, Matthew; Barber, Mark; Bhalla, Ajay; Cameron, Alan; Dyker, Alexander; Guyler, Paul; Hassan, Ahamad; Kearney, Mark T.; Keegan, Breffni; Lakshmanan, Sekaran; Macleod, Mary Joan; Randall, Marc; Shaw, Louise; Subramanian, Ganesh; Werring, David; McConnachie, Alex

Citation

Dawson , J , Robertson , M , Dickie , D A , Bath , P , Forbes , K , Quinn , T , Broomfield , N M , Dani , K , Doney , A , Houston , G , Lees , K R , Muir , K W , Struthers , A , Walters , M , Barber , M , Bhalla , A , Cameron , A , Dyker , A , Guyler , P , Hassan , A , Kearney , M T , Keegan , B , Lakshmanan , S , Macleod , M J , Randall , M , Shaw , L , Subramanian , G , Werring , D & McConnachie , A 2023 , ' Xanthine oxidase inhibition and white matter hyperintensity progression following ischaemic stroke and transient ischaemic attack (XILO-FIST): a multicentre, double-blinded, randomised, placebo-controlled trial ' , EClinicalMedicine , vol. 57 , 101863 . https://doi.org/10.1016/j.eclinm.2023.101863